Pharmacokinetics and exposure–safety relationship of ciprofol for sedation in mechanically ventilated patients in the intensive care unit
Abstract Ciprofol (HSK3486) is a newly developed, highly selective γ‐aminobutyric acid‐A (GABAA) receptor potentiator that is recently approved for a new indication of sedation for patients in the intensive care unit (ICU) in China. This analysis aimed to characterize the population pharmacokinetics...
Saved in:
| Main Authors: | Lu Liu, Kun Wang, Zhongyi Sun, Pangke Yan, Mengyue Hu, Xiao Liu, Meixia Chen, Nan Wu, Xiaoqiang Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-05-01
|
| Series: | CPT: Pharmacometrics & Systems Pharmacology |
| Online Access: | https://doi.org/10.1002/psp4.13121 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ciprofol versus propofol for long-term sedation in mechanically ventilated patients with sepsis: a randomized controlled trial
by: Feng-Zhi Zhao, et al.
Published: (2025-04-01) -
Early sedation using ciprofol for intensive care unit patients requiring mechanical ventilation: a pooled post-hoc analysis of data from phase 2 and phase 3 trials
by: Yongjun Liu, et al.
Published: (2024-10-01) -
A chronopharmacological comparison of ciprofol and propofol: focus on sedation and side effects
by: Xuehan Li, et al.
Published: (2025-04-01) -
Efficacy and safety of ciprofol for sedation/anesthesia in patients undergoing hysteroscopy: a prospective, randomized, non-inferiority trial
by: Shi Cheng, et al.
Published: (2025-12-01) -
Pharmacokinetics and pharmacodynamics of ciprofol after continuous infusion in elderly patients
by: Xiaowen Guo, et al.
Published: (2025-01-01)